Clinical dermatology company Botanix Pharmaceuticals (ASX:BOT) has announced that Ascent Health, the second largest Payer organisation in the US, will cover Sofdra (sofpironium) topical gel, 12.45 per cent. …
Botanix expands US payer coverage for Sofdra with Ascent Health agreement
November 14, 2024 Australian Biotech
Latest Video
New Stories
-
A response based on short-term considerations only undermines long-term objectives
November 15, 2024 - - Latest News -
Amplia enters into preclinical collaboration with Korean drug screening company
November 14, 2024 - - Australian Biotech -
Botanix expands US payer coverage for Sofdra with Ascent Health agreement
November 14, 2024 - - Australian Biotech -
Australian company says 'Efti' INSIGHT-003 lung cancer trial reveals positive survival data
November 14, 2024 - - Latest News -
'A procurement mindset must not impede equitable access to medicines that offer significant benefits'
November 14, 2024 - - Latest News -
MA proposes CEO for HTA Review implementation group and wants 'continuity'
November 14, 2024 - - Latest News -
Any approach to government relations based on the Montessori method is doomed to fail
November 14, 2024 - - Latest News